Hypothalamic-pituitary-adrenal axis and clinical symptoms in first-episode psychosis.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Psychoneuroendocrinology

• Publication date

  2012-05-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.psyneuen.2011.08.013PMID 21930345
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diagnostic and Statistical Manual of Mental Disorders

  2013cited by this paper
• Cortisol and dehydroepiandrosterone-sulphate levels correlate with symptom severity in first-episode psychosis.

  2011influential reference
• Effect of antipsychotic treatment on Insulin-like Growth Factor-1 and cortisol in schizophrenia: a longitudinal study.

  2010cited by this paper
• Antipsychotic dose equivalents and dose-years: a standardized method for comparing exposure to different drugs.

  2010cited by this paper
• Reduced folic acid, vitamin B12 and docosahexaenoic acid and increased homocysteine and cortisol in never-medicated schizophrenia patients: implications for altered one-carbon metabolism.

  2010cited by this paper
• A systematic review of hypothalamic–pituitary–adrenal axis function in schizophrenia: implications for mortality

  2010influential reference
• Pregnenolone, Dehydroepiandrosterone, and Schizophrenia: Alterations and Clinical Trials

  2010cited by this paper
• Abnormal cortisol levels during the day and cortisol awakening response in first-episode psychosis: the role of stress and of antipsychotic treatment.

  2010cited by this paper
• Higher cortisol levels are associated with smaller left hippocampal volume in first-episode psychosis.

  2010cited by this paper
• Meta-analysis and meta-regression of hypothalamic-pituitary-adrenal axis activity in functional somatic disorders.

  2010cited by this paper
• Abnormal cortisol awakening response predicts worse cognitive function in patients with first-episode psychosis

  2010cited by this paper
• Diurnal cortisol patterns of young male patients with schizophrenia

  2010cited by this paper
• Olanzapine shifts the temporal relationship between the daily acrophase of serum prolactin and cortisol concentrations rhythm in healthy men.

  2009cited by this paper
• The brain and the stress axis: The neural correlates of cortisol regulation in response to stress

  2009cited by this paper
• Treatment of schizophrenia with antipsychotics in Norwegian emergency wards, a cross-sectional national study

  2009cited by this paper
• The cortisol awakening response (CAR): facts and future directions.

  2009cited by this paper
• Associations between sociodemographic, sampling and health factors and various salivary cortisol indicators in a large sample without psychopathology.

  2009cited by this paper
• Salivary cortisol as a biomarker in stress research.

  2009cited by this paper
• Functional neuroimaging in schizophrenia: diagnosis and drug discovery.

  2008cited by this paper
• Glucocorticoid antagonists in neuropsychiatric [corrected] disorders.

  2008cited by this paper
• Pituitary volume in unaffected relatives of patients with schizophrenia and bipolar disorder.

  2008cited by this paper
• Sex differences in the cortisol response to awakening in recent onset psychosis.

  2008influential reference
• Pituitary volume in psychosis: the first review of the evidence

  2008cited by this paper
• Stress and the hypothalamic pituitary adrenal axis in the developmental course of schizophrenia.

  2008influential reference
• Persistent negative symptoms in schizophrenia: an overview.

  2007cited by this paper
• Normal pituitary volumes in chronic schizophrenia.

  2007cited by this paper
• Symptom rating scales and outcome in schizophrenia

  2007cited by this paper
• Diagnostic stability over 3 years in a total group of first-episode psychosis patients

  2007cited by this paper
• Physiology and neurobiology of stress and adaptation: central role of the brain.

  2007cited by this paper
• Circulatory neurosteroid levels in smoking and non-smoking chronic schizophrenia patients.

  2007influential reference
• Increased Levels of Nitric Oxide, Cortisol and Adrenomedullin in Patients with Chronic Schizophrenia

  2007cited by this paper
• State and trait related predictors of serum cortisol to DHEA(S) molar ratios and hormone concentrations in schizophrenia patients.

  2007cited by this paper
• Insulin and insulin-like growth factor-1 abnormalities in antipsychotic-naive schizophrenia.

  2007cited by this paper
• Salivary cortisol secretion in remitted bipolar patients and offspring of bipolar parents.

  2006cited by this paper
• Nocturnal hormone profiles in patients with schizophrenia treated with olanzapine.

  2006cited by this paper
• Cortisol circadian rhythm alterations in psychotic major depression.

  2006cited by this paper
• Distribution of symptom dimensions across Kraepelinian divisions

  2006cited by this paper
• The atypical antipsychotics olanzapine and quetiapine, but not haloperidol, reduce ACTH and cortisol secretion in healthy subjects

  2006cited by this paper
• Dexamethasone suppression test in first-episode schizophrenia.

  2006cited by this paper
• Cortisol and Cytokines in Chronic and Treatment-Resistant Patients with Schizophrenia: Association with Psychopathology and Response to Antipsychotics

  2005influential reference
• Remission in schizophrenia: proposed criteria and rationale for consensus.

  2005cited by this paper
• Negative Correlation between Negative Symptoms of Schizophrenia and Testosterone Levels

  2004cited by this paper
• Evidence of basal pituitary-adrenal overactivity in first episode, drug naïve patients with schizophrenia.

  2004cited by this paper
• Hypothalamic-pituitary-adrenal axis function in patients with bipolar disorder

  2004cited by this paper
• The Relationship of Sex Hormones and Cortisol with Cognitive functioning in Schizophrenia

  2004influential reference
• Increased circulatory dehydroepiandrosterone and dehydroepiandrosterone-sulphate in first-episode schizophrenia: relationship to gender, aggression and symptomatology.

  2004cited by this paper
• Hormonal responses during prolonged exercise are influenced by a selective DA/NA reuptake inhibitor

  2004cited by this paper
• The Cortisol Awakening Response in Bipolar Illness: A Pilot Study

  2003cited by this paper
• Two formulas for computation of the area under the curve represent measures of total hormone concentration versus time-dependent change.

  2003cited by this paper
• Dopamine and serotonin function in untreated schizophrenia: clinical correlates of the apomorphine and d-fenfluramine tests.

  2003cited by this paper
• The factor structure for the Positive and Negative Syndrome Scale (PANSS) in recent-onset psychosis.

  2003cited by this paper
• Social environment, ethnicity and schizophrenia. A case-control study.

  2002cited by this paper
• Regional specificity of brain glucocorticoid receptor mRNA alterations in subjects with schizophrenia and mood disorders

  2002cited by this paper
• Social environment, ethnicity and schizophrenia

  2002cited by this paper
• Validity of the depressive dimension extracted from principal component analysis of the PANSS in drug-free patients with schizophrenia.

  2002cited by this paper
• Correlation of plasma neurosteroid levels to the severity of negative symptoms in male patients with schizophrenia.

  2002influential reference
• Use of salivary biomarkers in biobehavioral research: cotton-based sample collection methods can interfere with salivary immunoassay results.

  2001cited by this paper
• Simultaneous stimulation of growth hormone, adrenocorticotropin and cortisol with L‐dopa/L‐carbidopa and propranolol in children of short stature

  2000cited by this paper
• Cognitive functioning, cortisol release, and symptom severity in patients with schizophrenia.

  2000influential reference
• Prolactin hyperresponsiveness to D-fenfluramine in drug-free schizophrenic patients: a placebo-controlled study.

  1999cited by this paper
• Switch from neuroleptics to clozapine does not influence pituitary-gonadal axis hormone levels in male schizophrenic patients.

  1999cited by this paper
• Platelet 5-HT levels and hypothalamic-pituitary-adrenal axis activity in schizophrenic patients with positive and negative symptoms.

  1997cited by this paper
• Salivary cortisol in psychoneuroendocrine research: recent developments and applications.

  1994cited by this paper
• Hypothalamic-pituitary-adrenal axis function in chronic schizophrenia: association with clinical features.

  1992influential reference
• Depressed nocturnal plasma melatonin levels in drug-free paranoid schizophrenics.

  1992cited by this paper
• [Dexamethasone suppression test and the positive and negative symptoms of schizophrenia].

  1991influential reference
• A polydiagnostic application of operational criteria in studies of psychotic illness. Development and reliability of the OPCRIT system.

  1991cited by this paper
• The Incidence of Abnormal Dexamethasone Suppression in Schizophrenia: A Review and a Meta-Analytic Comparison with the Incidence in Normal Controls

  1990cited by this paper
• Dexamethasone suppression test in positive and negative schizophrenia.

  1989cited by this paper
• Neurobiological effects of lumbar puncture stress in psychiatric patients and healthy volunteers.

  1988cited by this paper
• The positive and negative syndrome scale (PANSS) for schizophrenia.

  1987cited by this paper
• Raised Plasma Cortisol Concentrations a Feature of Drug-Free Psychotics and not Specific for Depression

  1986influential reference
• The dexamethasone suppression test in residual schizophrenia with depression.

  1984cited by this paper
• Serum cortisol in chronic schizophrenia. A study of the siurnal rhythm in relation to psychiatric mental status.

  1971influential reference
• Psychoendocrinology of ego disintegration.

  1970cited by this paper

• Divergent Inflammatory Profiles but No Predictive Biomarkers of Psychiatric Sequelae After Viral Infection: A 12-Month Cohort Study.

  2026cites this paper
• Cortisol in schizophrenia spectrum disorders: A comprehensive meta-analysis.

  2025cites this paper
• The Etiological Role of Impaired Neurogenesis in Schizophrenia: Interactions with Inflammatory, Microbiome and Hormonal Signaling

  2025cites this paper
• Struggling Can Also Show on the Inside: Current Knowledge of the Impact of Childhood Maltreatment on Biomarkers in Mood Disorders

  2024cites this paper
• Correlates of Attenuated Positive Psychotic Symptoms in a Non-Clinical Sample: Perceived Discrimination, Stress, and Substance Use

  2023cites this paper
• Examining the psychobiological response to acute social stress across clinical stages and symptom trajectories in the early psychosis continuum.

  2023cites this paper
• Immune marker levels in severe mental disorders: associations with polygenic risk scores of related mental phenotypes and psoriasis

  2022cites this paper
• Childhood adversity, symptoms, and cortisol in first episode psychosis: a cross-sectional, secondary, observational analysis of a subsample of FEP patients

  2022cites this paper
• Paternal age and specific neurological soft signs as reliable and valid neurobiological markers for the diagnosis of patients with schizophrenia

  2021cites this paper
• The implications of hypothalamic abnormalities for schizophrenia.

  2021cites this paper
• Comparison of inflammatory, nutrient, and neurohormonal indicators in patients with schizophrenia, bipolar disorder and major depressive disorder.

  2021cites this paper
• Taurine prevents MK-801-induced shoal dispersion and altered cortisol responses in zebrafish.

  2021cites this paper
• Efficacy of Spironolactone as an Adjunctive Therapy to Risperidone to Improve Symptoms of Schizophrenia: A Double-Blind, Randomized, Placebo-Controlled, Clinical Trial

  2021cites this paper
• Cortisol Levels in Childhood Associated With Emergence of Attenuated Psychotic Symptoms in Early Adulthood

  2021cites this paper
• Higher Serum C-Reactive Protein Levels in Catatonic Patients: A Comparison to Non-catatonic Patients and Healthy Controls.

  2020cites this paper
• Differentiating between bipolar and unipolar depression using prefrontal activation patterns: Promising results from functional near infrared spectroscopy (fNIRS) findings.

  2020cites this paper
• Incongruent Expression of Brain-Derived Neurotrophic Factor and Cortisol in Schizophrenia: Results from a Randomized Controlled Trial of Laughter Intervention

  2020cites this paper
• Childhood Trauma in Psychoses

  2020cites this paper
• Decoding the impact of adverse childhood experiences on the progression of schizophrenia

  2019cites this paper
• The role of cortisol and prolactin in the pathogenesis and clinical expression of psychotic disorders.

  2019cites this paper
• Dissecting the syndrome of schizophrenia: Associations between symptomatology and hormone levels in women with schizophrenia.

  2019cites this paper
• Cortisol awakening response is decreased in patients with first-episode psychosis and increased in healthy controls with a history of severe childhood abuse.

  2019cites this paper
• Transcriptional changes in the stress pathway are related to symptoms in schizophrenia and to mood in schizoaffective disorder.

  2019cites this paper
• Understanding the link between childhood trauma and schizophrenia: a systematic review of neuroimaging studies.

  2019cites this paper
• Sleep-endocrine effects of growth hormone-releasing hormone (GHRH) in patients with schizophrenia.

  2018cites this paper
• Understanding the impact of environmental stress : the effect of childhood abuse on brain structure and stress response systems in psychosis

  2018cites this paper
• Clinical correlates of hypothalamic-pituitary-adrenal axis measures in individuals at risk for psychosis and with first-episode psychosis.

  2018cites this paper
• Physiological and Affective Reactivity to Emotional Comments in Individuals at High Risk for Psychosis

  2018cites this paper
• The hypothalamus and neuropsychiatric disorders: psychiatry meets microscopy

  2018cites this paper
• Depression in cirrhosis – a prospective evaluation of the prevalence, predictors and development of a screening nomogram

  2018cites this paper
• Is psychosis a multisystem disorder? A meta-review of central nervous system, immune, cardiometabolic, and endocrine alterations in first-episode psychosis and perspective on potential models

  2018cites this paper
• Biomarkers and schizophrenia : a qualitative review REVIEW

  2017cites this paper
• The relationship between cannabis use and cortisol levels in youth at ultra high-risk for psychosis.

  2017cites this paper
• Convergence of Aberrant Electrophysiological Correlates of Salience, Affective Processing and Stress Reactivity in Patients with Schizophrenia

  2017cites this paper
• Childhood predictors of written expression in late adolescents with 22q11.2 deletion syndrome: a longitudinal study

  2017cites this paper
• The neural diathesis‐stress model of schizophrenia revisited: An update on recent findings considering illness stage and neurobiological and methodological complexities

  2017cites this paper
• Cortisol in schizophrenia: No association with tobacco smoking, clinical symptoms or antipsychotic medication

  2017influential citation
• Childhood Adversity, Cortisol Levels, and Psychosis: A Retrospective Investigation

  2017cites this paper
• Maternal viral infection during pregnancy elicits anti-social behavior in neonatal piglet offspring independent of postnatal microglial cell activation.

  2017cites this paper
• Toward a unified theory of childhood trauma and psychosis: A comprehensive review of epidemiological, clinical, neuropsychological and biological findings

  2017cites this paper
• Theranostic Biomarkers for Schizophrenia

  2017cites this paper
• Cortisol awakening response in patients with psychosis: Systematic review and meta-analysis.

  2016cites this paper
• Neuroactive Steroids in First-Episode Psychosis: A Role for Progesterone?

  2016cites this paper
• Diurnal cortisol variation and cortisol response to an MRI stressor in schizophrenia and bipolar disorder.

  2016cites this paper
• The HPA axis in bipolar disorder: Systematic review and meta-analysis.

  2016cites this paper
• Sex differences in morning cortisol in youth at ultra-high-risk for psychosis.

  2016cites this paper
• Social Adversity in the Etiology of Psychosis: A Review of the Evidence.

  2016cites this paper
• The Dopamine Hypothesis of Schizophrenia

  2016cites this paper
• Ýlk Atak Þizofreni Hastalarýnda Antipsikotik Tedaviye Yanýtý Belirleyen Yordayýcý Faktörler Predictive Factors of Antipsychotic Treatment Response in Patients With First Episode Schizophrenia

  2016cites this paper
• The effects of olanzapine treatment on brain regional glucose metabolism in neuroleptic‐naive first‐episode schizophrenic patients

  2016cites this paper
• Resting cortisol level, self-concept, and putative familial environment in adolescents at ultra high-risk for psychotic disorders.

  2015cites this paper
• Cortisol and Inflammatory Biomarkers Predict Poor Treatment Response in First Episode Psychosis

  2015cites this paper
• Abnormalities in neuroendocrine stress response in psychosis: the role of endocannabinoids

  2015influential citation
• The effect of storage conditions on salivary cortisol concentrations using an Enzyme Immunoassay

  2015cites this paper
• Evaluating subjective domains of antipsychotic‐induced adverse effects using heart rate variability

  2015cites this paper
• Cortisol Reactivity to Stress and Its Association With White Matter Integrity in Adults With Schizophrenia

  2015cites this paper
• Cumulative stress pathophysiology in schizophrenia as indexed by allostatic load.

  2015cites this paper
• Much ado about much: stress, dynamic biomarkers and HPA axis dysregulation along the trajectory to psychosis.

  2015cites this paper
• Refining and integrating schizophrenia pathophysiology - relevance of the allostatic load concept.

  2014cites this paper
• The Role of Cortisol in First Episode of Psychosis: A Systematic Review

  2014cites this paper
• Blunted cortisol awakening response in people at ultra high risk of developing psychosis.

  2014cites this paper
• Neurobiological effects of physical exercise in schizophrenia: a systematic review

  2014cites this paper
• The traumagenic neurodevelopmental model of psychosis revisited

  2014cites this paper
• Positive symptoms in first-episode psychosis patients experiencing low maternal care and stressful life events: a pilot study to explore the role of the COMT gene

  2014cites this paper
• Increased stress susceptibility and hypothalamic-pituitary-adrenal axis dysfunction : early markers of psychosis vulnerability?

  2014cites this paper
• Fresh approaches to antidepressant drug discovery

  2014cites this paper
• Morning cortisol levels in schizophrenia and bipolar disorder: a meta-analysis.

  2014cites this paper
• The Interface of Stress and the HPA Axis in Behavioural Phenotypes of Mental Illness.

  2014cites this paper
• Leukocyte Gene Expression in Patients with Medication Refractory Depression before and after Treatment with ECT or Isoflurane Anesthesia: A Pilot Study

  2014cites this paper
• Flattened cortisol awakening response in chronic patients with schizophrenia onset after cannabis exposure.

  2014cites this paper
• Plasma cortisol levels and illness appraisal in deficit syndrome schizophrenia.

  2014cites this paper
• The traumagenic neurodevelopmental model of psychosis revisited Practice

  2014cites this paper
• Females with schizophrenia have abnormal functional cortical connectivity in the gamma frequency during an auditory oddball task using magnetoencephalography

  2014cites this paper
• Version Other version Link to publication record in King ' s Research Portal

  2014cites this paper
• Circadian and homeostatic modulation of functional connectivity and regional cerebral blood flow in humans under normal entrained conditions

  2014cites this paper
• HPA axis response to social stress is attenuated in schizophrenia but normal in depression: evidence from a meta-analysis of existing studies.

  2014cites this paper
• Pituitary gland volume in at-risk mental state for psychosis: a longitudinal MRI analysis

  2014cites this paper
• Cortisol awakening response and diurnal cortisol among children at elevated risk for schizophrenia: Relationship to psychosocial stress and cognition

  2014cites this paper
• First-Episode Psychosis: An Inflammatory State?

  2014cites this paper
• Pituitary gland volume in patients with schizophrenia, subjects at ultra high-risk of developing psychosis and healthy controls: a systematic review and meta-analysis.

  2013cites this paper
• The dietary pattern of patients with schizophrenia: a systematic review.

  2013cites this paper
• A systematic review of the activity of the hypothalamic-pituitary-adrenal axis in first episode psychosis.

  2013cites this paper
• Neuroendocrine Profile in a Rat Model of Psychosocial Stress: Relation to Oxidative Stress

  2013cites this paper
• Cortisol levels and risk for psychosis: initial findings from the North American prodrome longitudinal study.

  2013cites this paper
• Stress and neurodevelopmental processes in the emergence of psychosis.

  2013cites this paper
• Sleep Dysfunction Prior to the Onset of Schizophrenia: A Review and Neurodevelopmental Diathesis–Stress Conceptualization

  2013cites this paper
• Treatment Response in First-episode Schizophrenia

  2012cites this paper
• Stress abnormalities in individuals at risk for psychosis: a review of studies in subjects with familial risk or with "at risk" mental state.

  2012influential citation
• HPA-axis function, symptoms, and medication exposure in youths at clinical high risk for psychosis.

  2012cites this paper
• Enlarged hypothalamic volumes in schizophrenia.

  2012cites this paper
• Hormones and schizophrenia

  2012cites this paper